The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn-, maternal fetal health-, and prenatal screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
What we offer:
For more information please contact Leader of Global Regulatory Affairs Kirsi-Marja Meri on May 21st between 12 –13, or May 24th between 12 –13 +358 40 5808 378 or by e-mail Kirsi-Marja.Meri@perkinelmer.com.
If you are interested in the position and feel that you have the necessary skills and experience, please send your application and CV by 27th May, 2018 via the link below.
PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.